We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$104B
AUM Growth
+$6.58B
Cap. Flow
-$453M
Cap. Flow %
-0.43%
Top 10 Hldgs %
10.66%
Holding
2,865
New
128
Increased
1,119
Reduced
1,402
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 17.57%
2 Industrials 13.85%
3 Financials 12.11%
4 Consumer Discretionary 11.36%
5 Healthcare 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFL icon
2551
SFL Corp
SFL
$1.61B
$124K ﹤0.01%
16,151
-500
-3% -$4.09K
EGY icon
2552
Vaalco Energy
EGY
$594M
$121K ﹤0.01%
37,160
-42,360
-53% -$117K
BWAY
2553
Brainsway
BWAY
$622M
$119K ﹤0.01%
23,358
CARM
2554
DELISTED
Carisma Therapeutics
CARM
$119K ﹤0.01%
1,283
+75
+6% +$4.78K
ATOS icon
2555
Atossa Therapeutics
ATOS
$23.5M
$117K ﹤0.01%
1,231
+495
+67% +$26.2K
BTU icon
2556
Peabody Energy
BTU
$2.9B
$114K ﹤0.01%
14,405
-591
-4% -$3.5K
ARQ icon
2557
Arq
ARQ
$89.3M
$114K ﹤0.01%
15,397
+5,117
+50% +$31.5K
ALSK
2558
DELISTED
Alaska Communications Systems
ALSK
$113K ﹤0.01%
33,864
+15,994
+90% +$53K
ASXC
2559
DELISTED
Asensus Surgical, Inc.
ASXC
$112K ﹤0.01%
35,275
-1,001
-3% -$2.5K
SRI icon
2560
Stoneridge
SRI
$213M
$111K ﹤0.01%
3,760
BBDC icon
2561
Barings BDC
BBDC
$965M
$109K ﹤0.01%
10,293
-317
-3% -$3.31K
HBIO icon
2562
Harvard Bioscience
HBIO
$29.2M
$109K ﹤0.01%
1,311
-1,289
-50% -$91.2K
XXII
2563
22nd Century Group
XXII
$1.48M
0
CYBE
2564
DELISTED
Cyberoptics Corp
CYBE
$109K ﹤0.01%
2,672
+32
+1% +$993
CODX
2565
Co-Diagnostics
CODX
$5.6M
$104K ﹤0.01%
+422
New +$108K
KRRO icon
2566
Korro Bio
KRRO
$195M
$104K ﹤0.01%
209
-11
-5% -$5.37K
STXS icon
2567
Stereotaxis
STXS
$141M
$104K ﹤0.01%
10,744
-270
-2% -$2.13K
VSTM icon
2568
Verastem
VSTM
$610M
$103K ﹤0.01%
2,099
-39
-2% -$1.63K
HROW icon
2569
Harrow
HROW
$1.51B
$102K ﹤0.01%
10,929
+569
+5% +$4.85K
PGEN icon
2570
Precigen
PGEN
$2.59B
$102K ﹤0.01%
15,612
+153
+1% +$1.07K
KOPN icon
2571
Kopin
KOPN
$791M
$101K ﹤0.01%
12,370
-85
-0.7% -$704
NATR icon
2572
Nature's Sunshine
NATR
$288M
$100K ﹤0.01%
+5,760
New +$114K
UTMD icon
2573
Utah Medical Products
UTMD
$225M
$100K ﹤0.01%
1,180
ARDX icon
2574
Ardelyx
ARDX
$997M
$96K ﹤0.01%
12,599
-62
-0.5% -$458
GNSS icon
2575
Genasys
GNSS
$79.2M
$96K ﹤0.01%
17,500
-1,100
-6% -$6.71K

Similar funds

Victory Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Victory Capital Management held 2,865 positions worth $104B, up 6.7% from $97.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Victory Capital Management's Q2 2021 filing shows 128 new, 1,119 increased, 1,402 reduced and 129 closed positions. Its largest new stake was iShares Core S&P Mid-Cap ETF: 6,251,880 shares worth $336M. The largest sale was Darden Restaurants, an estimated $302M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q2 2021 buy was iShares Core S&P Mid-Cap ETF: 6,251,880 shares worth $336M.
  • Victory Capital Management added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $1.28B increase.
  • Victory Capital Management's biggest Q2 2021 reduction was Darden Restaurants, cutting an estimated $302M.
  • Victory Capital Management fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $245M.
  • Victory Capital Management's ten largest holdings make up 11% of its $104B portfolio in Q2 2021.
  • Victory Capital Management opened 128 new positions and closed 129 in Q2 2021.
  • Victory Capital Management's portfolio value rose 6.7% quarter-over-quarter to $104B.

Based on Victory Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.